NASDAQ:LNTH - New England Nuclear Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$14.55 +0.45 (+3.19 %)
(As of 05/27/2018 11:34 AM ET)
Previous Close$14.55
Today's Range$13.95 - $14.60
52-Week Range$13.55 - $24.45
Volume395,822 shs
Average Volume432,382 shs
Market Capitalization$556.99 million
P/E Ratio14.55
Dividend YieldN/A
Beta1.51

About New England Nuclear (NASDAQ:LNTH)

New England Nuclear logoLantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases worldwide. Its principal products include DEFINITY, an ultrasound contrast agent used in ultrasound exams of the heart; TechneLite, a technetium generator that provides the essential nuclear material used in nuclear medicine procedures; and Xenon, a radiopharmaceutical gas used to assess pulmonary function and imaging cerebral blood flow. The company also offers Neurolite, an injectable that is used to identify the area in the brain where blood flow has been blocked or reduced due to stroke; and Cardiolite, an injectable technetium-labeled imaging agent used in myocardial perfusion imaging (MPI) procedures that assess blood flow distribution to the heart. In addition, it provides injectable radiopharmaceutical imaging agents, such as Thallium Tl 201 that is used in MPI studies to detect cardiovascular disease; Gallium Ga 67, which is used to detect various infections and cancerous tumors; FDG, a fluorine-18-radiolabeled imaging agent to identify and characterize tumors in patients undergoing oncologic diagnostic procedures; and Quadramet, a therapeutic product, which is used to treat severe bone pain associated with metastatic bone lesions. Further, the company is developing Flurpiridaz F 18, which is in Phase III clinical trials to assess blood flow to the heart; LMI 1195 that has completed Phase I clinical trials for assessing cardiac sympathetic nerve function; and LMI 1174, which is in pre-clinical development targeted to elastin in the arterial walls and atherosclerotic plaque. The company sells its products to hospitals, clinics, group practices, integrated delivery networks, group purchasing organizations, and radiopharmacies. Lantheus Holdings, Inc. was founded in 1956 and is headquartered in North Billerica, Massachusetts.

Receive LNTH News and Ratings via Email

Sign-up to receive the latest news and ratings for LNTH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Diagnostic substances
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:LNTH
CUSIPN/A
Phone978-671-8001

Debt

Debt-to-Equity Ratio7.87
Current Ratio3.51
Quick Ratio2.80

Price-To-Earnings

Trailing P/E Ratio14.55
Forward P/E Ratio16.92
P/E Growth1.42

Sales & Book Value

Annual Sales$331.38 million
Price / Sales1.68
Cash Flow$1.5832 per share
Price / Cash9.19
Book Value$0.88 per share
Price / Book16.53

Profitability

EPS (Most Recent Fiscal Year)$1.00
Net Income$123.38 million
Net Margins38.32%
Return on Equity-145.14%
Return on Assets11.84%

Miscellaneous

Employees483
Outstanding Shares38,280,000

New England Nuclear (NASDAQ:LNTH) Frequently Asked Questions

What is New England Nuclear's stock symbol?

New England Nuclear trades on the NASDAQ under the ticker symbol "LNTH."

How were New England Nuclear's earnings last quarter?

New England Nuclear Co. (NASDAQ:LNTH) released its quarterly earnings results on Wednesday, May, 2nd. The medical equipment provider reported $0.22 earnings per share for the quarter, hitting the consensus estimate of $0.22. The medical equipment provider earned $82.63 million during the quarter, compared to the consensus estimate of $81.15 million. New England Nuclear had a net margin of 38.32% and a negative return on equity of 145.14%. The company's revenue for the quarter was up 1.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.11 EPS. View New England Nuclear's Earnings History.

What price target have analysts set for LNTH?

4 brokers have issued 1 year price objectives for New England Nuclear's stock. Their predictions range from $22.00 to $27.00. On average, they anticipate New England Nuclear's share price to reach $24.00 in the next twelve months. View Analyst Ratings for New England Nuclear.

Are investors shorting New England Nuclear?

New England Nuclear saw a decrease in short interest during the month of May. As of May 15th, there was short interest totalling 666,888 shares, a decrease of 25.7% from the April 30th total of 897,426 shares. Based on an average daily volume of 522,577 shares, the short-interest ratio is currently 1.3 days. Currently, 1.8% of the shares of the company are sold short.

Who are some of New England Nuclear's key competitors?

Who are New England Nuclear's key executives?

New England Nuclear's management team includes the folowing people:
  • Ms. Mary Anne Heino, CEO, Pres & Director (Age 58)
  • Mr. John W. Crowley, CFO & Treasurer (Age 54)
  • Mr. Michael P. Duffy, Sr. VP of Strategy & Bus. Devel., Gen. Counsel and Sec. (Age 57)
  • Mr. Timothy G. Healey, Sr. VP of Commercial (Age 52)
  • Mr. William C. Dawes Jr., VP of Manufacturing and Operations (Age 46)

When did New England Nuclear IPO?

(LNTH) raised $75 million in an initial public offering on Thursday, June 25th 2015. The company issued 7,900,000 shares at $8.50-$10.50 per share. Citigroup, Jefferies, RBC Capital Markets and Wells Fargo Securities acted as the underwriters for the IPO and Baird was co-manager.

Has New England Nuclear been receiving favorable news coverage?

News articles about LNTH stock have been trending somewhat positive on Sunday, Accern reports. The research group scores the sentiment of media coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. New England Nuclear earned a news impact score of 0.09 on Accern's scale. They also gave news coverage about the medical equipment provider an impact score of 46.06 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.

How do I buy shares of New England Nuclear?

Shares of LNTH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is New England Nuclear's stock price today?

One share of LNTH stock can currently be purchased for approximately $14.55.

How big of a company is New England Nuclear?

New England Nuclear has a market capitalization of $556.99 million and generates $331.38 million in revenue each year. The medical equipment provider earns $123.38 million in net income (profit) each year or $1.00 on an earnings per share basis. New England Nuclear employs 483 workers across the globe.

How can I contact New England Nuclear?

New England Nuclear's mailing address is 331 TREBLE COVE ROAD, NORTH BILLERICA MA, 01862. The medical equipment provider can be reached via phone at 978-671-8001 or via email at [email protected]


MarketBeat Community Rating for New England Nuclear (LNTH)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  172 (Vote Outperform)
Underperform Votes:  149 (Vote Underperform)
Total Votes:  321
MarketBeat's community ratings are surveys of what our community members think about New England Nuclear and other stocks. Vote "Outperform" if you believe LNTH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LNTH will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

New England Nuclear (NASDAQ:LNTH) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
4 Wall Street analysts have issued ratings and price targets for New England Nuclear in the last 12 months. Their average twelve-month price target is $24.00, suggesting that the stock has a possible upside of 64.95%. The high price target for LNTH is $27.00 and the low price target for LNTH is $22.00. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.752.752.752.75
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $24.00$24.00$24.00$24.00
Price Target Upside: 64.95% upside6.19% upside6.19% upside6.19% upside

New England Nuclear (NASDAQ:LNTH) Consensus Price Target History

Price Target History for New England Nuclear (NASDAQ:LNTH)

New England Nuclear (NASDAQ:LNTH) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/3/2017Jefferies GroupBoost Price TargetBuy$22.00 ➝ $27.00N/AView Rating Details
11/3/2017Credit Suisse GroupBoost Price TargetNeutral$19.00 ➝ $23.00N/AView Rating Details
11/2/2017Wells Fargo & CoUpgradeMarket Perform ➝ OutperformN/AView Rating Details
7/17/2017Cantor FitzgeraldInitiated CoverageOverweight$22.00HighView Rating Details
11/8/2016Royal Bank of CanadaBoost Price TargetOutperform$6.00 ➝ $12.00N/AView Rating Details
(Data available from 5/27/2016 forward)

Earnings

New England Nuclear (NASDAQ:LNTH) Earnings History and Estimates Chart

Earnings by Quarter for New England Nuclear (NASDAQ:LNTH)

New England Nuclear (NASDAQ:LNTH) Earnings Estimates

2018 EPS Consensus Estimate: $0.67
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.20$0.20$0.20
Q2 20181$0.13$0.13$0.13
Q3 20181$0.16$0.16$0.16
Q4 20181$0.18$0.18$0.18

New England Nuclear (NASDAQ LNTH) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/2/2018Q1$0.22$0.22$81.15 million$82.63 millionViewListenView Earnings Details
2/26/2018Q4 2017$0.20$0.12$78.57 million$81.24 millionViewListenView Earnings Details
11/2/2017Q3 2017$0.20$0.24$77.18 million$79.94 millionViewN/AView Earnings Details
8/1/2017Q2 2017$0.24$0.42$80.56 million$88.83 millionViewListenView Earnings Details
5/2/2017Q1 2017$0.19$0.28$77.75 million$81.36 millionViewListenView Earnings Details
2/21/2017Q416$0.13$0.18$70.78 million$74.35 millionViewListenView Earnings Details
11/1/2016Q3 2016$0.08$0.15$70.10 million$73.06 millionViewN/AView Earnings Details
8/4/2016Q216$0.06$0.24$72.66 million$78.00 millionViewListenView Earnings Details
5/3/2016Q116$0.06$0.15$72.43 million$76.50 millionViewListenView Earnings Details
2/22/2016Q415$0.02$0.13$71.47 million$71.00 millionViewListenView Earnings Details
11/4/2015Q315$0.04$0.18$73.65 million$74.10 millionViewListenView Earnings Details
8/4/2015Q215($0.14)$0.05$72.41 million$73.30 millionViewListenView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

New England Nuclear (NASDAQ:LNTH) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

New England Nuclear (NASDAQ LNTH) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.20%
Institutional Ownership Percentage: 92.51%
Insider Trading History for New England Nuclear (NASDAQ:LNTH)
Institutional Ownership by Quarter for New England Nuclear (NASDAQ:LNTH)

New England Nuclear (NASDAQ LNTH) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/30/2018Cesare OrlandiInsiderSell8,801$18.00$158,418.0097,216View SEC Filing  
4/26/2018Cesare OrlandiInsiderSell4,194$18.00$75,492.00108,311View SEC Filing  
4/3/2018Michael P DuffyInsiderSell27,313$15.30$417,888.90191,472View SEC Filing  
3/14/2018Michael P DuffyInsiderSell11,492$16.60$190,767.20View SEC Filing  
2/26/2018Timothy G HealeySVPSell3,696$19.58$72,367.6864,582View SEC Filing  
1/16/2018John W CrowleyCFOSell3,866$23.52$90,928.32View SEC Filing  
1/10/2018Michael P DuffyInsiderSell21,655$22.40$485,072.00156,784View SEC Filing  
11/17/2017Timothy G HealeySVPSell11,314$21.51$243,364.14View SEC Filing  
11/14/2017Michael P DuffyInsiderSell11,917$21.63$257,764.71152,301View SEC Filing  
10/13/2017John W CrowleyCFOSell6,755$18.41$124,359.55View SEC Filing  
9/13/2017Derace L SchafferDirectorSell15,000$17.50$262,500.0048,730View SEC Filing  
9/11/2017Michael P DuffyInsiderSell20,000$16.45$329,000.00184,218View SEC Filing  
9/7/2017David F BurgstahlerDirectorSell102,958$16.56$1,704,984.4813,248View SEC Filing  
9/6/2017David F BurgstahlerDirectorSell78,833$16.95$1,336,219.3513,248View SEC Filing  
9/5/2017Cesare OrlandiInsiderSell18,000$16.69$300,420.0087,078View SEC Filing  
9/5/2017David F BurgstahlerDirectorSell52,010$17.08$888,330.8013,248View SEC Filing  
9/1/2017David F BurgstahlerDirectorSell6,000$17.10$102,600.0013,248View SEC Filing  
8/31/2017David F BurgstahlerDirectorSell230,685$17.25$3,979,316.2513,248View SEC Filing  
8/28/2017David F BurgstahlerDirectorSell91,166$17.01$1,550,733.6613,248View SEC Filing  
8/16/2017Avista Capital Partners Gp, LlMajor ShareholderSell12,128$17.05$206,782.40View SEC Filing  
8/16/2017David F BurgstahlerDirectorSell140,846$17.27$2,432,410.4213,248View SEC Filing  
8/15/2017Avista Capital Partners Gp, LlMajor ShareholderSell40,779$17.06$695,689.74View SEC Filing  
8/14/2017Avista Capital Partners Gp, LlMajor ShareholderSell87,939$17.40$1,530,138.60View SEC Filing  
7/12/2017Mary Anne HeinoCEOSell10,000$18.05$180,500.00592,468View SEC Filing  
6/20/2017David F BurgstahlerDirectorSell3,000,000$14.87$44,610,000.00View SEC Filing  
6/12/2017Mary Anne HeinoCEOSell10,000$15.39$153,900.00602,468View SEC Filing  
6/12/2017Michael P DuffyInsiderSell20,000$15.42$308,400.00188,234View SEC Filing  
5/10/2017Derace L SchafferDirectorSell10,000$15.75$157,500.0063,730View SEC Filing  
5/9/2017Avista Capital Partners Gp, LlMajor ShareholderSell3,000,000$13.40$40,200,000.00View SEC Filing  
5/9/2017Derace L SchafferDirectorSell10,000$14.75$147,500.0073,730View SEC Filing  
3/17/2017David F BurgstahlerDirectorSell3,000,000$12.20$36,600,000.00View SEC Filing  
11/21/2016David F BurgstahlerDirectorSell2,500,000$9.00$22,500,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

New England Nuclear (NASDAQ LNTH) News Headlines

Source:
DateHeadline
Lantheus Holdings, Inc. to Present at the Jefferies 2018 Global Healthcare ConferenceLantheus Holdings, Inc. to Present at the Jefferies 2018 Global Healthcare Conference
finance.yahoo.com - May 23 at 4:35 PM
Financial Comparison: New England Nuclear (LNTH) & Idexx Laboratories (IDXX)Financial Comparison: New England Nuclear (LNTH) & Idexx Laboratories (IDXX)
www.americanbankingnews.com - May 20 at 9:53 AM
New England Nuclear Co. (LNTH) Receives Average Recommendation of "Hold" from BrokeragesNew England Nuclear Co. (LNTH) Receives Average Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - May 19 at 1:34 AM
New England Nuclear Co. (LNTH) Expected to Announce Quarterly Sales of $88.35 MillionNew England Nuclear Co. (LNTH) Expected to Announce Quarterly Sales of $88.35 Million
www.americanbankingnews.com - May 16 at 4:02 AM
Zacks: Brokerages Expect New England Nuclear Co. (LNTH) to Post $0.21 EPSZacks: Brokerages Expect New England Nuclear Co. (LNTH) to Post $0.21 EPS
www.americanbankingnews.com - May 14 at 9:32 AM
New England Nuclear Co. (LNTH) Short Interest UpdateNew England Nuclear Co. (LNTH) Short Interest Update
www.americanbankingnews.com - May 13 at 2:28 AM
New England Nuclear (LNTH) Downgraded to "Sell" at ValuEngineNew England Nuclear (LNTH) Downgraded to "Sell" at ValuEngine
www.americanbankingnews.com - May 10 at 8:13 PM
Lantheus Holdings, Inc. to Present at the 2018 UBS Global Healthcare ConferenceLantheus Holdings, Inc. to Present at the 2018 UBS Global Healthcare Conference
finance.yahoo.com - May 9 at 9:30 AM
BidaskClub Lowers New England Nuclear (LNTH) to HoldBidaskClub Lowers New England Nuclear (LNTH) to Hold
www.americanbankingnews.com - May 8 at 3:49 PM
New England Nuclear Co. (LNTH) Forecasted to Post Q2 2018 Earnings of $0.13 Per ShareNew England Nuclear Co. (LNTH) Forecasted to Post Q2 2018 Earnings of $0.13 Per Share
www.americanbankingnews.com - May 7 at 1:58 AM
Jefferies Group Analysts Cut Earnings Estimates for New England Nuclear Co. (LNTH)Jefferies Group Analysts Cut Earnings Estimates for New England Nuclear Co. (LNTH)
www.americanbankingnews.com - May 4 at 8:37 AM
Edited Transcript of LNTH earnings conference call or presentation 2-May-18 8:30pm GMTEdited Transcript of LNTH earnings conference call or presentation 2-May-18 8:30pm GMT
finance.yahoo.com - May 3 at 4:25 PM
New England Nuclear (LNTH) Releases Quarterly  Earnings Results, Meets EstimatesNew England Nuclear (LNTH) Releases Quarterly Earnings Results, Meets Estimates
www.americanbankingnews.com - May 3 at 2:54 PM
Critical Review: Vermillion (VRML) and New England Nuclear (LNTH)Critical Review: Vermillion (VRML) and New England Nuclear (LNTH)
www.americanbankingnews.com - May 3 at 5:49 AM
Lantheus Holdings, Inc. Reports 2018 First Quarter ResultsLantheus Holdings, Inc. Reports 2018 First Quarter Results
finance.yahoo.com - May 2 at 4:31 PM
New England Nuclear (LNTH) Lifted to Hold at Zacks Investment ResearchNew England Nuclear (LNTH) Lifted to Hold at Zacks Investment Research
www.americanbankingnews.com - May 2 at 11:02 AM
Cesare Orlandi Sells 8,801 Shares of New England Nuclear Co. (LNTH) StockCesare Orlandi Sells 8,801 Shares of New England Nuclear Co. (LNTH) Stock
www.americanbankingnews.com - May 1 at 7:34 PM
Head to Head Comparison: New England Nuclear (LNTH) vs. Its RivalsHead to Head Comparison: New England Nuclear (LNTH) vs. Its Rivals
www.americanbankingnews.com - May 1 at 11:22 AM
New England Nuclear (LNTH) Raised to Buy at BidaskClubNew England Nuclear (LNTH) Raised to Buy at BidaskClub
www.americanbankingnews.com - May 1 at 7:16 AM
New England Nuclear (LNTH) versus The Competition Head to Head SurveyNew England Nuclear (LNTH) versus The Competition Head to Head Survey
www.americanbankingnews.com - May 1 at 1:08 AM
New England Nuclear Co. (LNTH) Insider Cesare Orlandi Sells 4,194 SharesNew England Nuclear Co. (LNTH) Insider Cesare Orlandi Sells 4,194 Shares
www.americanbankingnews.com - April 27 at 7:26 PM
Reviewing New England Nuclear (LNTH) and Its CompetitorsReviewing New England Nuclear (LNTH) and Its Competitors
www.americanbankingnews.com - April 27 at 5:20 PM
New England Nuclear (LNTH) versus Its Competitors Financial ContrastNew England Nuclear (LNTH) versus Its Competitors Financial Contrast
www.americanbankingnews.com - April 24 at 7:24 PM
New England Nuclear Co. (LNTH) Receives Consensus Recommendation of "Hold" from BrokeragesNew England Nuclear Co. (LNTH) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - April 24 at 1:30 AM
Critical Review: New England Nuclear (LNTH) & Its RivalsCritical Review: New England Nuclear (LNTH) & Its Rivals
www.americanbankingnews.com - April 23 at 7:18 PM
Reviewing New England Nuclear (LNTH) & The CompetitionReviewing New England Nuclear (LNTH) & The Competition
www.americanbankingnews.com - April 20 at 11:14 PM
New England Nuclear (LNTH) Downgraded by Zacks Investment Research to "Hold"New England Nuclear (LNTH) Downgraded by Zacks Investment Research to "Hold"
www.americanbankingnews.com - April 19 at 8:31 PM
Lantheus Holdings to Host First Quarter 2018 Earnings Conference Call on May 2, 2018 at 4:30 p.m. Eastern TimeLantheus Holdings to Host First Quarter 2018 Earnings Conference Call on May 2, 2018 at 4:30 p.m. Eastern Time
finance.yahoo.com - April 18 at 4:42 PM
Head-To-Head Comparison: New England Nuclear (LNTH) & The CompetitionHead-To-Head Comparison: New England Nuclear (LNTH) & The Competition
www.americanbankingnews.com - April 18 at 1:20 AM
New England Nuclear (LNTH) Coverage Initiated at Cantor FitzgeraldNew England Nuclear (LNTH) Coverage Initiated at Cantor Fitzgerald
www.americanbankingnews.com - April 17 at 11:58 PM
New England Nuclear (LNTH) & Its Competitors Head to Head SurveyNew England Nuclear (LNTH) & Its Competitors Head to Head Survey
www.americanbankingnews.com - April 17 at 9:14 PM
New England Nuclear (LNTH) Receives "Buy" Rating from Jefferies GroupNew England Nuclear (LNTH) Receives "Buy" Rating from Jefferies Group
www.americanbankingnews.com - April 14 at 10:17 AM
New England Nuclear (LNTH) PT Raised to $19.00New England Nuclear (LNTH) PT Raised to $19.00
www.americanbankingnews.com - April 14 at 9:09 AM
New England Nuclear Co. (LNTH) Short Interest Up 51.9% in MarchNew England Nuclear Co. (LNTH) Short Interest Up 51.9% in March
www.americanbankingnews.com - April 14 at 1:41 AM
Zacks Investment Research Upgrades New England Nuclear (LNTH) to Strong-BuyZacks Investment Research Upgrades New England Nuclear (LNTH) to Strong-Buy
www.americanbankingnews.com - April 13 at 1:35 PM
Critical Comparison: New England Nuclear (LNTH) and Achieve Life Sciences (ACHV)Critical Comparison: New England Nuclear (LNTH) and Achieve Life Sciences (ACHV)
www.americanbankingnews.com - April 12 at 5:27 PM
Critical Comparison: New England Nuclear (LNTH) and The CompetitionCritical Comparison: New England Nuclear (LNTH) and The Competition
www.americanbankingnews.com - April 9 at 7:21 PM
Michael P. Duffy Sells 27,313 Shares of Lantheus Holdings Inc (LNTH) StockMichael P. Duffy Sells 27,313 Shares of Lantheus Holdings Inc (LNTH) Stock
www.americanbankingnews.com - April 5 at 7:14 PM
Lantheus (LNTH) Lowered to Hold at ValuEngineLantheus (LNTH) Lowered to Hold at ValuEngine
www.americanbankingnews.com - April 3 at 12:11 PM
Head to Head Review: Lantheus (LNTH) and Its PeersHead to Head Review: Lantheus (LNTH) and Its Peers
www.americanbankingnews.com - April 2 at 1:16 PM
Lantheus (LNTH) Upgraded to Outperform at Wells FargoLantheus (LNTH) Upgraded to Outperform at Wells Fargo
www.americanbankingnews.com - April 2 at 8:22 AM
Lantheus (LNTH) Upgraded to Strong-Buy by Zacks Investment ResearchLantheus (LNTH) Upgraded to Strong-Buy by Zacks Investment Research
www.americanbankingnews.com - April 1 at 6:28 PM
Zacks Investment Research Lowers Lantheus (LNTH) to HoldZacks Investment Research Lowers Lantheus (LNTH) to Hold
www.americanbankingnews.com - March 31 at 11:00 PM
Lantheus (LNTH) Upgraded to Buy at Zacks Investment ResearchLantheus (LNTH) Upgraded to Buy at Zacks Investment Research
www.americanbankingnews.com - March 30 at 11:10 PM
Lantheus (LNTH) Rating Lowered to Hold at Zacks Investment ResearchLantheus (LNTH) Rating Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - March 30 at 8:24 PM
Lantheus Holdings Inc (LNTH) Given Consensus Recommendation of "Hold" by AnalystsLantheus Holdings Inc (LNTH) Given Consensus Recommendation of "Hold" by Analysts
www.americanbankingnews.com - March 30 at 1:32 AM
Lantheus (LNTH) Rating Increased to Hold at BidaskClubLantheus (LNTH) Rating Increased to Hold at BidaskClub
www.americanbankingnews.com - March 28 at 10:44 AM
Lantheus (LNTH) Upgraded by TheStreet to "C-"Lantheus (LNTH) Upgraded by TheStreet to "C-"
www.americanbankingnews.com - March 21 at 1:10 PM
Lantheus Holdings Inc (LNTH) Insider Michael P. Duffy Sells 11,492 SharesLantheus Holdings Inc (LNTH) Insider Michael P. Duffy Sells 11,492 Shares
www.americanbankingnews.com - March 16 at 8:15 PM
Lantheus Presents New Data on Novel Cardiac PET Imaging Agent LMI 1195 in Development for the Diagnostic Assessment of Ischemic Heart Failure Patients at Risk for Sudden Cardiac Death at ACC.18Lantheus Presents New Data on Novel Cardiac PET Imaging Agent LMI 1195 in Development for the Diagnostic Assessment of Ischemic Heart Failure Patients at Risk for Sudden Cardiac Death at ACC.18
finance.yahoo.com - March 12 at 10:58 AM

SEC Filings

New England Nuclear (NASDAQ:LNTH) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

New England Nuclear (NASDAQ:LNTH) Income Statement, Balance Sheet and Cash Flow Statement

Chart

New England Nuclear (NASDAQ LNTH) Stock Chart for Sunday, May, 27, 2018

Loading chart…

This page was last updated on 5/27/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.